Open AccessEstablishment of an oligoasthenospermia mouse model based on TAp73 gene suppression
Author(s) -
Liu HongJuan,
Deng MengYun,
Zhu YanYan,
Wu DeLing,
Tong XiaoHui,
Li Li,
Wang Lei,
Xu Fei,
Wang TongSheng
Publication year - 2021
Publication title -
animal models and experimental medicine
Language(s) - English
Resource type - Journals
ISSN - 2576-2095
DOI - 10.1002/ame2.12186
Subject(s) - sertoli cell , sperm , biology , andrology , germ cell , spermatogenesis , motility , sperm motility , male infertility , transfection , microbiology and biotechnology , gene , oligospermia , downregulation and upregulation , infertility , genetics , endocrinology , medicine , pregnancy
Abstract Background Oligoasthenospermia is one of the main causes of male infertility. Researchers usually use chemical drugs to directly damage germ cells to prepare oligoasthenospermia models, which disregards the adhesion and migration between spermatogenic cells and Sertoli cells. TAp73 is a critical regulator of the adhesin of germ cell; thus, we sought to explore a novel oligoasthenospermia model based on TAp73 gene suppression. Methods Mice in the Pifithrin‐α group were injected intraperitoneally with 2.5 mg/kg Pifithrin‐α ( TAp73 inhibitor) daily for 30 consecutive days. Reproductive hormone levels and epididymal sperm quality, as well as the network morphology of Sertoli cells were tested. Results Sperm density, motility, and the relative protein and mRNA expression of TAp73 and Nectin 2 were obviously decreased in the Pifithrin‐α group compared with the normal control group. No significant distinction was observed in the relative mRNA and protein expression of ZO‐1 . Furthermore, the tight junctions (TJs) and apical ectoplasmic specialization (ES) were destroyed in the Pifithrin‐α group. Conclusion The above results indicate that we successfully established a new oligoasthenospermia mouse model. This study provides a foundation for further exploration of the roles of TAp73 genes during spermatogenesis and provides new research objects for further oligospermia research and future drug discovery.